CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Alphabet shares drop ahead of earnings next week
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
CVS Health (CVS) PT Raised to $91 at RBC Capital; Technical Issues Weighing on Shares
May 3, 2018 8:39 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $91.00 (from $89.00) while maintaining a Outperform rating.
Analyst George Hill commented, "CVS reported Q1 results that beat our estimates and consensus, driven by stronger- than-expected results in the Pharmacy/LTC... More



